omeprazole has been researched along with Sarcoidosis in 1 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Sarcoidosis: An idiopathic systemic inflammatory granulomatous disorder comprised of epithelioid and multinucleated giant cells with little necrosis. It usually invades the lungs with fibrosis and may also involve lymph nodes, skin, liver, spleen, eyes, phalangeal bones, and parotid glands.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Prednisone was continued with a slow taper, and after 1 month ber dysphagia had resolved and her esophageal manometry was normal." | 2.39 | Reversible esophageal motility disorder in a patient with sarcoidosis. ( Criss, DG; Geissinger, BW; Sharkey, MF; Wu, WC, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Geissinger, BW | 1 |
| Sharkey, MF | 1 |
| Criss, DG | 1 |
| Wu, WC | 1 |
1 review available for omeprazole and Sarcoidosis
| Article | Year |
|---|---|
Reversible esophageal motility disorder in a patient with sarcoidosis.
Topics: Adult; Deglutition Disorders; Drug Therapy, Combination; Esophageal Motility Disorders; Esophagus; F | 1996 |